Evidence map›Paper›PMID 33437213›Full record

ArticleInternational journal of medical sciences2021

Oral treatment for diabetes using α-glucosidase inhibitors was a risk factor for chronic obstructive pulmonary disease: a cohort study.

Sheng-Wen Wu, Yung-Chyuan Ho, Ci-Wen Luo, Hung-Yi Chen, Chun-Hung Su, Yu-Hsiang Kuan

Open access · goldAbstract read
In one paragraph

Article in International journal of medical sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Sheng-Wen WuDivision of Nephrology, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.
Yung-Chyuan HoSchool of Medical Applied Chemistry, Chung Shan Medical University, Taichung, Taiwan.
Ci-Wen LuoDepartment of Pharmacology, School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Hung-Yi ChenSchool of Pharmacy, China Medical University, Taichung, Taiwan.
Chun-Hung SuDepartment of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.
Yu-Hsiang KuanDepartment of Pharmacology, School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Chung Shan Medical University · TWChung Shan Medical University Hospital · TWChina Medical University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Administration, OralAdultAgedCase-Control StudiesComorbidityDiabetes MellitusFemaleFollow-Up StudiesGlycoside Hydrolase InhibitorsHumansIncidenceMaleMiddle AgedPulmonary Disease, Chronic ObstructiveRisk AssessmentRisk FactorsGlycoside Hydrolase Inhibitorschronic obstructive pulmonary diseasecohort studycox regressiondiabetes mellitusα-glucosidase inhibitor

Identifiers

PMID33437213
PMCPMC7797545
OpenAlexW3112644541

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.